• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Indivior Pharmaceuticals, Inc. - Common Stock (NQ:INDV)

37.66 +0.88 (+2.39%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Indivior Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Indivior (INDV) Q1 2026 Earnings Transcript ↗
Today 10:07 EDT
Indivior (INDV) Q1 2026 Earnings Transcript 
Via The Motley Fool
Indivior Pharmaceuticals Inc (NASDAQ:INDV) Smashes Q1 Estimates and Lifts Full-Year Outlook as SUBLOCADE Sales Surge ↗
April 30, 2026
Via Chartmill
News headline image
Indivior Reports First Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance
April 30, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder
April 24, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
Indivior Pharmaceuticals Inc (NASDAQ:INDV) Shows High Growth Momentum and Technical Breakout Potential ↗
April 21, 2026
Via Chartmill
Indivior Pharmaceuticals Inc (NASDAQ:INDV) Surpasses Q4 2025 Estimates and Provides Strong 2026 Outlook ↗
February 26, 2026
Via Chartmill
INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) Presents a High-Growth Momentum and Technical Setup Case ↗
February 20, 2026
Via Chartmill
News headline image
Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse
April 16, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th
April 09, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities
March 31, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder
March 17, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) Presents a High-Growth Momentum Breakout Setup ↗
January 27, 2026
Via Chartmill
News headline image
Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering
March 12, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Indivior Announces Proposed Convertible Senior Notes Offering
March 12, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder
March 11, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Divisadero Dumps Stride Stock ↗
March 06, 2026
Stride delivers technology-driven education solutions for K–12 and adult learners, serving schools, districts, and employers nationwide. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Indivior (INDV) Q4 2025 Earnings Call Transcript ↗
February 26, 2026
Indivior (INDV) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results
February 26, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Indivior to Participate in Upcoming Investor Conferences
February 24, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Vistance Networks Stock Up 250%. Here's Why a $40 Million Position Signals a Post-Divestiture Bet ↗
February 22, 2026
Vistance Networks delivers connectivity and network solutions for telecom, data centers, and enterprise clients worldwide. 
Via The Motley Fool
News headline image
Array Stock Down 25%, But This $17.3 Million Buy Signals Confidence Amid Big Revenue Growth ↗
February 22, 2026
Array Digital Infrastructure delivers wireless services and device sales to consumers, businesses, and government clients nationwide. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Enviri Stock Up 120% as $43 Million Buy Makes It a Top Holding in This Portfolio ↗
February 22, 2026
Enviri delivers environmental and specialty waste solutions for industrial clients through long-term contracts and value-added products. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Integer Stock Down 38%, but One Fund Just Bet $40 Million on a Turnaround ↗
February 22, 2026
Integer Holdings supplies medical device components and finished products to major OEMs in cardiac, neuro, and surgical markets. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26ᵗʰ
January 28, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Indivior Announces Completion of Redomiciliation to the United States
January 26, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Indivior Provides Full-Year 2026 Financial Guidance and Business Update
January 08, 2026
From Indivior Inc.
Via GlobeNewswire
News headline image
Mangrove Partners Loads Up Flywire With 2.9 Million Shares ↗
December 30, 2025
The new holding places Flywire outside the fund’s top five positions. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
INDIVIOR PLC (NASDAQ:INDV) Presents a High-Growth Momentum and Technical Breakout Setup ↗
December 29, 2025
INDIVIOR stock combines high-growth earnings momentum with a strong technical uptrend and a current bull flag setup for a potential breakout. 
Via Chartmill
News headline image
This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table ↗
December 28, 2025
When a biotech rallies nearly 200% and still gets trimmed, the real story likely isn’t about fear or a loss of conviction. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Bardin Hill Dumps 349,000 Shares of Frontier Communicaitons Stock Worth $12.7 Million ↗
December 18, 2025
The position previously accounted for 7.48% of fund AUM as of the prior quarter. 
Via The Motley Fool
Topics Initial Public Offering Regulatory Compliance
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap